U.S. Basic Materials Stock News

Rocket Companies (RKT) recently entered a new unsecured revolving credit agreement with a US$2.5b commitment maturing in 2029. This facility replaces its 2025 agreement and provides additional balance sheet flexibility for general corporate purposes. See our latest analysis for Rocket Companies. At a share price of US$13.98, Rocket Companies has seen a 3.63% 1 day and 2.42% 7 day share price return, yet its year to date share price return is down 29.68%. The 3 year total shareholder return of...

Cognex stock has delivered a strong 77.4% gain over the past year. However, both the Discounted Cash Flow (DCF) intrinsic value estimate and traditional market multiples currently point to the shares trading at a premium. With recent strong earnings news still fresh, investors are weighing whether the current price fully reflects the good news already. Cognex is up 77.4% over the past year, which means anyone looking at the stock today is stepping in after a substantial re rating. Stronger...

Intercontinental Exchange stock has delivered a 37.8% gain over the past three years. However, both its intrinsic value estimate from the Excess Returns model and its market multiples currently suggest the shares trade at a premium rather than at a clear discount. A 37.8% return over three years points to solid long term shareholder gains. This raises the bar for what counts as good value at today's price. New initiatives such as ICE IDs for private credit can support expectations for future...

Klarna Group (NYSE:KLAR) is back in focus after Klarna AB was announced as the leasing provider behind Apple’s new Apple Upgrade program in the United States, covering iPhone, Mac, iPad and Apple Watch. See our latest analysis for Klarna Group. The Apple Upgrade partnership has arrived while Klarna Group’s 90 day share price return is up 39%, even though the year to date share price return is down 34.51%, so recent momentum is improving from a weaker start to the year. If this kind of...

In its latest quarterly update, Collegium Pharmaceutical reported US$193.5 million in revenue, topping analyst estimates and delivering earnings per share ahead of expectations, but issued full-year revenue guidance that fell short of consensus forecasts. This contrast between strong recent execution and more cautious guidance has sharpened investor focus on how management views the company’s medium-term growth prospects and product momentum. We’ll now examine how Collegium’s revenue beat...

Coca-Cola stock jumped 5% to US$88.27 in the first trading session after earnings, which suggests investors quickly liked what they saw. The headline is simple: this quarter was about earnings power. Basic earnings per share for Q2 landed at about US$1.03 on revenue of roughly US$13.38b, with management highlighting margin expansion and strong free cash flow. For a company often treated as a steady bond substitute in a portfolio, that kind of profit focus can matter more than spectacle. The...

AngloGold Ashanti recently faced analyst earnings estimate downgrades after a period of weaker gold prices, following an earlier quarter where earnings were supported by high gold prices despite flat production and rising costs. This shift highlights how sensitive the miner’s earnings outlook is to gold price movements when operational volumes are steady and cost pressures intensify. We’ll now examine how these analyst downgrades tied to softer gold prices may alter AngloGold Ashanti’s...

Kennametal (KMT) is back on investors’ radar after the company announced that long serving director Joseph Alvarado will become Chairman of the Board in October 2026, succeeding retiring chair William M. Lambert. See our latest analysis for Kennametal. The board change comes as Kennametal’s share price sits at US$35.61, with a 1 day share price return of 0.82% and a year to date share price return of 22.84%, while the 1 year total shareholder return of 45.19% points to stronger momentum over...

Edwards Lifesciences reported its second-quarter 2026 results in July, with sales rising to US$1,741 million from US$1,532.2 million a year earlier, while net income and earnings per share declined, and the company issued third-quarter guidance for total sales of US$1.63 billion to US$1.71 billion. Alongside these results, Edwards Lifesciences raised its full-year 2026 sales growth guidance, including higher targets for its TAVR and TMTT product groups, signaling management’s increased...

NOV Inc. has reported its second-quarter 2026 results, with revenue of US$2,134 million versus US$2,188 million a year earlier, net income of US$112 million versus US$108 million, and has guided third-quarter consolidated revenue to be flat to up 2% year over year. Alongside slightly lower sales, NOV grew quarterly earnings per share and continued executing its buyback, retiring 3,200,000 shares for US$63 million in the latest tranche. Next, we'll examine how NOV's combination of modest...

Innodata (INOD) has drawn fresh attention after record revenue growth and an expanded earnings outlook highlighted its role in AI data engineering. New platform offerings and broader customer demand are now central to the latest move in the stock. See our latest analysis for Innodata. Despite the strong business update, Innodata’s recent share price momentum has cooled, with the stock down 22.11% over the past month but still showing a 44.08% 90 day share price return and a very large 5 year...

United Airlines Holdings (UAL) has moved back into focus after issuing tighter earnings guidance for 2026 and the third quarter, tying its outlook to higher oil prices and a shifting operating backdrop. See our latest analysis for United Airlines Holdings. United Airlines Holdings shares have been volatile, with a 2.65% 1 day share price return and 5.55% 7 day share price return, set against a 30 day share price decline of 8.45% and a 37.52% 90 day share price return. The 1 year total...

Over the last 7 days, the United States market has experienced a 1.5% decline, yet it has shown resilience with a 16% rise over the past year and expectations for earnings to grow by 17% annually in the coming years. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider activity could offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.

Over the last 7 days, the United States market has experienced a 1.5% decline, although it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying stocks that are believed to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst broader market growth trends.

Over the last 7 days, the United States market has experienced a 1.5% drop, yet it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In such an environment, growth stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and potential for significant revenue expansion.

Over the last 7 days, the United States market has dropped 1.5%, yet it remains up 16% over the past year, with earnings anticipated to grow by 17% per annum in the coming years. In such a landscape, identifying stocks with strong financials is crucial for investors seeking opportunities beyond traditional large-cap investments. Penny stocks, despite their somewhat outdated moniker, continue to intrigue investors due to their potential for value and growth; we'll explore several that stand...

Over the last 7 days, the United States market has experienced a 1.5% drop, yet it has risen by 16% over the past year with earnings forecast to grow by 17% annually. In this dynamic environment, reliable dividend stocks can offer investors a steady income stream and potential for capital appreciation.

Anyone interested in Olema Pharmaceuticals, Inc. ( NASDAQ:OLMA ) should probably be aware that the Independent...

The fact that multiple Oculis Holding AG ( NASDAQ:OCS ) insiders offloaded a considerable amount of shares over the...

Kinder Morgan, Inc. ( NYSE:KMI ) stock is about to trade ex-dividend in four days. The ex-dividend date occurs one day...

Even though Allogene Therapeutics, Inc. ( NASDAQ:ALLO ) has fallen by 10% over the past week , insiders who sold...

As you might know, Las Vegas Sands Corp. ( NYSE:LVS ) last week released its latest second-quarter, and things did not...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Whilst it may not be a huge deal, we thought it was good to see that the Oak Valley Bancorp ( NASDAQ:OVLY ) Independent...